Norway· NO-ID_72ED2A9E-6DD0-4B5D-BF3A-21E55FEC983B
Cifoban
A hemofiltrates product containing sodium citrate, registered in Norway by Fresenius Medical Care Deutschland GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Sodium citrate is registered in 11 of 19 countries.
Countries holding a registration under ATC B05ZB (hemofiltrates), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Sodium citrate · ATC B05ZB
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Sodium Citrate
- Manufacturer
- Fresenius Medical Care Deutschland GmbH
- Country
- Norway (NO)
- ATC code
- B05ZB
- ATC class
- Hemofiltrates
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_72ED2A9E-6DD0-4B5D-BF3A-21E55FEC983B
- no_varenummer0427958 x 1500NOK 3360
- gtin4046241120295
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sodium citrate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCIFOBAN 136 MMOL/L SOLUCION PARA PERFUSIONFresenius Medical Care Deutschland Gmbh
- FranceCIVARON 136 mmol/L, solution pour perfusionFRESENIUS MEDICAL CARE DEUTSCHLAND (ALLEMAGNE)
- United KingdomCifoban 204mmol/1.5litre solution for extracorporeal infusion bagsFresenius Medical Care (UK) Ltd
- SwedenCivaron 136 mmol/l Infusionsvätska, lösningFresenius Medical Care Deutschland GmbH
- Japanクエン酸ナトリウム水和物扶桑薬品工業
- GermanyCivaronFresenius Medical Care Deutschland Gmbh
- CanadaANTICOAGULANT SOD CITRATE SOLTN 4GM/100MLBAXTER CORPORATION
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Citravyl, Natriumcitrat Grifols
- Belgium · Civastyn
- Bulgaria · Цифобан
- Cyprus · Cifoban
- Czechia · Cigenta, Natrium Citrát Grifols
- Germany · Civaron, Natriumcitrat Grifols
- Denmark · Cifoban
- Estonia · Cigenta
- Spain · Cifoban, Citrato De Sodio Grifols
- Finland · Cifoban
- France · Civaron
- United Kingdom (Northern Ireland) · Canesoasis Cystitis Relief, Cifoban
- Greece · Cifoban
- Croatia · Civaron
- Hungary · Cifoban, Nátrium-Citrát Grifols
- Ireland · Cifoban
- Italy · Cifoban, Sodio Citrato Galenica Senese
- Lithuania · Cigenta
- Luxembourg · Civastyn
- Latvia · Civaron
- Netherlands · Cifoban
- Poland · Cifoban
- Portugal · Civastyn
- Romania · Cifoban
- Sweden · Civaron
- Slovenia · Cigenta
- Slovakia · Cifoban
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3c93776-1ed7-4adc-bb8b-67c819ab6d57 GET /v1/drugs/b3c93776-1ed7-4adc-bb8b-67c819ab6d57?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Hemofiltrasjonsvæsker",
"merkevare_id": "ID_72ED2A9E-6DD0-4B5D-BF3A-21E55FEC983B",
"name_form_strength": "Cifoban inf, oppl 136 mmol/L",
"prescription_group": "C"
}See everything about sodium citrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.